Contract Win

TIDMIMTK

Imaginatik PLC

08 March 2011

8 March 2011

Imaginatik Plc

("Imaginatik" or the "Company")

Contract Win

Imaginatik plc (AIM: IMTK.L), a leading provider of innovation management software and consultancy, is pleased to announce the signing of an annual software license with a leading US-based provider of pharmacy and clinical research services. Financial terms have not been disclosed.

This contract is the conversion of a pilot project. Under the terms of the agreement, Imaginatik will deliver its Idea Central software via a hosted environment to enable 24,000 of the customer's employees to access and participate in the company's innovation initiative.

Matt Cooper, Executive Chairman of Imaginatik, commented: "We are delighted another major player in the pharmaceutical industry has chosen us as their innovation partner following the successful completion of the Idea Central pilot programme. This further endorses the quality of our software and the material results it delivers for our customers. Alongside our long-standing pharmaceutical customers such as Pfizer and Novartis, this gives us further traction in the innovation centric pharma and healthcare industries."

For further information please contact:

 
 Imaginatik plc                          Tel: 020 7917 2975 
 Matt Cooper, Chairman / Shawn Taylor, 
  CFO 
 
 Arbuthnot Securities Limited            Tel: 020 7012 2000 
 Tom Griffiths 
 
 Threadneedle Communications             Tel: 020 7653 9850 
 Caroline Evans-Jones / Hilary Millar

About Imaginatik

Imaginatik provides Innovation and Idea management solutions comprised of consultancy, software (Idea Central) and program management to deliver innovation outcomes to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte. For more information visit www.imaginatik.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NRABIGDXRXGBGBR

Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024